"To better serve patients throughout the greater St. Louis area, Siteman Cancer Center has expanded to north St. Louis County. This new location brings nationally-recognized cancer care, including clinical trials for innovative cancer therapies, to residents in north St. Louis, the northern St. Louis suburbs, southern Illinois, and beyond."

During the past decade, Siteman Cancer Center at Christian Hospital conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 16 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 14 clinical trials were completed. i.e. 20.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siteman Cancer Center at Christian Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 72 trials, followed by "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored and "NRG Oncology" with 14 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siteman Cancer Center at Christian Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 53 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Siteman Cancer Center at Christian Hospital" are "Invasive Breast Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Metastatic Malignant Solid Neoplasm" (7 trials), "Anatomic Stage IV Breast Cancer AJCC v8" (6 trials) and "Metastatic Breast Carcinoma" (6 trials). Many other conditions were trialed in "Siteman Cancer Center at Christian Hospital" in a lesser frequency.

Most popular intervention types in "Siteman Cancer Center at Christian Hospital" are "Drug" (113 trials), "Other" (67 trials), "Biological" (57 trials), "Procedure" (51 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (30 trials), "Quality-of-Life Assessment" (30 trials), "Biospecimen Collection" (28 trials), "Questionnaire Administration" (26 trials) and "Nivolumab" (23 trials). Other intervention names were less common.

The vast majority of trials in "Siteman Cancer Center at Christian Hospital" are 117 trials for "All" genders, 8 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Siteman Cancer Center at Christian Hospital". undefined are not yet recruiting, 65 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Siteman Cancer Center at Christian Hospital, 8 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Siteman Cancer Center at Christian Hospital, 19 "Phase 1" clinical trials were conducted, 65 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".